A recent meta-analysis of 80 studies involving 33,160 older individuals aged 60–88 years found shared biomarkers between frailty and sarcopenia, including albumin and hemoglobin, which could one day allow for monitoring of the frailty phenotype and aid in clinical decision-making [65]. Here, ALB is linked to sarcopenia.